|
WO2021070187A1
|
|
Use of mechanical properties of cells in cancer detection methods
|
|
WO2021064730A1
|
|
Liposomal cannabinoids and uses thereof
|
|
WO2021059270A2
|
|
TREATMENT OF GENETIC DISEASES CHARACTERIZED BY UNSTABLE mRNAs
|
|
WO2021048844A1
|
|
Tomato plants having fruit with high zeaxanthin content
|
|
WO2021028917A1
|
|
Phytocannabinoids for preventing or treating non-alcoholic fatty liver disease, dyslipidemia, and type 2 diabetes
|
|
WO2021028916A1
|
|
Pharmaceutical compositions comprising a combination of opioid antagonists
|
|
WO2021024260A1
|
|
Novel peripheral cannabinoid-1 receptor antagonists
|
|
WO2021024256A1
|
|
Anticancer agents
|
|
WO2021009755A1
|
|
Protective coating for plants and postharvest plant matter
|
|
WO2020255137A1
|
|
Machine learning-based anomaly detection
|
|
WO2020255138A1
|
|
Composites and uses thereof
|
|
WO2020255132A1
|
|
An endoscopic retrograde cholangiopancreatography (ercp) catheter and guidewire with sensors and methods of using the same
|
|
WO2020255122A1
|
|
Method of treating or preventing retinopathy
|
|
WO2020240565A1
|
|
Compositions for delivery of ladostigil
|
|
WO2020230122A1
|
|
Peptides for the treatment of cancer
|
|
WO2020225816A1
|
|
Lipid profiling methods for predicting positive pregnancy outcome
|
|
WO2020225813A1
|
|
Restoration of the cftr function by splicing modulation
|
|
US2020348544A1
|
|
Integrated frequency referencing system
|
|
WO2020212992A2
|
|
Cancer cell methylation markers and use thereof
|
|
WO2020212976A1
|
|
Self-emulsifying drug delivery systems for delivery of lipophilic compounds
|
